Theratechnologies (TH) Stock Price Down 0.4%

Shares of Theratechnologies Inc (TSE:TH) traded down 0.4% on Friday . The stock traded as low as C$6.60 and last traded at C$6.73. 40,632 shares changed hands during mid-day trading, a decline of 73% from the average session volume of 152,300 shares. The stock had previously closed at C$6.70.

Several analysts recently weighed in on the stock. Scotiabank cut their price target on shares of Theratechnologies from C$9.50 to C$9.25 and set an “outperform” rating on the stock in a report on Friday, September 29th. National Bank Financial lifted their price target on shares of Theratechnologies from C$9.25 to C$9.75 and gave the company an “outperform” rating in a report on Friday, October 6th.

ILLEGAL ACTIVITY NOTICE: This story was posted by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are viewing this story on another publication, it was illegally stolen and republished in violation of U.S. & international trademark & copyright law. The correct version of this story can be viewed at https://www.dispatchtribunal.com/2017/12/10/theratechnologies-th-stock-price-down-0-4.html.

Theratechnologies Company Profile

Theratechnologies Inc is a specialty pharmaceutical company. The Company addresses medical needs to promote healthy living among human immunodeficiency virus (HIV) patients. Its products include EGRIFTA and Ibalizumab. EGRIFTA (tesamorelin for injection) refers to tesamorelin and it is indicated for the reduction of excess abdominal fat in HIV infected patients with lipodystrophy.

Receive News & Ratings for Theratechnologies Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Theratechnologies Inc and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply